Cardiac Point-of-Care (POC) Market Size, Share, Growth Report 2032

According to the report published by Zion Market Research, the global Cardiac Point-of-Care (POC) Market size was valued at USD 1,680.70 Million in 2022 and is predicted to reach USD 3,608.90 Million by the end of 2030. The market is expected to grow with a CAGR of 10.02% during the forecast period. The report analyzes the global Cardiac Point-of-Care (POC) Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Cardiac Point-of-Care (POC) Market industry.

Request Free Sample

Global Cardiac Point-of-Care (POC) Market: Overview

Cardiac POC is a type of blood test which also includes testing of the cholesterol and coagulation. Cardiac POC helps in the detection of the enzyme that is released if a person is suffering from critical cardiac illness. Enzymes can be lactate, brain natriuretic peptides, troponin, and dehydrogenase isoenzymes. Cardiac POCs are also helpful in detecting other conditions such as angina and myocardial infarction. The cardiac POC provides precise information about the markers that are released when the heart fails. Owing to the test the turnaround time minimizes thus helping in early diagnosis.

Global Cardiac Point-of-Care (POC) Market: Growth Factors

Some of the factors that are driving the growth of the cardiac point-of-care (POC) market are the growing numbers of the cardiac patients and the increasing requirement to diagnose these diseases. Moreover, the decrease in the turnaround time and availability of the technically advanced products having enhanced characteristics such as automation and miniaturization is also propelling the growth of the market.

Factors that are limiting the growth of the cardiac point-of-care (POC) market are a financial downturn and the concerns regarding reimbursement. One of the challenges faced by the market is the lack of precise actions in detecting the existence of the cardiovascular diseases.

The introduction of the novel products, mergers and acquisitions by the market players, and the increasing diagnostic facilities are some of the trends that are positively affecting the growth of the market.

Request Free Sample

Global Cardiac Point-of-Care (POC) Market: Segmentation

The cardiac point-of-care (POC) market is segmented based on the device type. On the basis of the device type, the market is segregated into cardiac POC testing analyzer and cardiac POC test kits. The cardiac POC test kits are further sub-divided into biomarker test, myoglobin biomarker test, myoglobin biomarker test, cardiac troponin biomarker test, hybrid test, creatine kinase-myoglobin (CK-MB), and brain natriuretic peptide (BNP) test.

Cardiac Point-of-Care (POC) Market: Report Scope

Global Cardiac Point-of-Care (POC) Market: Regional Analysis

North America is dominating the cardiac point-of-care (POC) market which is followed by Europe. The major factors that are driving the market are the growing demand for the home healthcare, increased number of cardiac patients, and the favorable government policies. Other factors that are positively influencing the market growth are favorable healthcare reforms, early adoption of the advanced technologies, advanced healthcare infrastructure, a wide range of upgradation in the Clinical Laboratory Improvement Amendments (CLIA) waved measures and the increased health awareness among the patients. The cardiac point-of-care (POC) market in Europe is positively affected due to the increased occurrences of chronic ailments, improved focus in the advancement of the connected healthcare, and the growing demand for the POC testing devices.

The cardiac point-of-care (POC) market in the Asia Pacific is expected to develop at a rapid rate in the coming years owing to the increasing healthcare spending and the growing awareness about the diagnostic treatments.

Global Cardiac Point-of-Care (POC) Market: Competitive Players

Some of the most important market players in the cardiac point-of-care (POC) market include :

• Alere Inc.
• Boston Scientific Corp.
• Abbott Laboratories
• Roche Diagnostics
• Medtronic Inc.,
• among others.

The global Cardiac Point-of-Care (POC) Market is segmented as follows:

By Device Type 

• cardiac POC testing analyzer and 
• cardiac POC test kits

By further sub-divided 

• biomarker test
• myoglobin biomarker test
• myoglobin biomarker test 
• cardiac troponin biomarker test
• hybrid test 
• creatine kinase-myoglobin (CK-MB) 
• and brain natriuretic peptide (BNP) test

Global Cardiac Point-of-Care (POC) Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • The UK
  • France
  • Germany
• The Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.